The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis

Anti-carbamylated protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA) and arthralgia patients at risk of developing RA.

See All

Key take away

In this study, the researcher observed that anti-carbamylated protein (anti-CarP) antibodies occur in almost all forms of early arthritis. For the future prospects, triple positivity score may also be used to identify future RA patients among individuals that do not yet display clinical symptoms as showed in this study.

Background

Anti-carbamylated protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA) and arthralgia patients at risk of developing RA. To what extent these autoantibodies are specific for RA is unknown. Therefore, we investigated the diagnostic performance of the presence of anti-CarP antibodies for RA in a setting of early arthritis.

Method

Anti-CarP antibodies were detected using carbamylated fetal calf serum as substrate. Anti-CCP2 antibodies were measured using enzyme-linked immunosorbent assay and immunoglobulin M (IgM) rheumatoid factor (RF) as part of routine care. Sera were derived from patients in the Leiden Early Arthritis Clinic cohort obtained at inclusion. Test characteristics were determined using the fulfillment of the 2010 RA criteria after 1 year as outcome.

Result

In total 2086 early arthritis patients were studied regarding the presence of anti-CarP antibodies. We observed that the sensitivity and specificity of the presence of anti-CarP antibodies for RA were 44 % and 89 %, respectively. As a reference, sensitivity and specificity of the presence of anti-CCP2 antibodies were 54 % and 96 %, respectively, and of IgM-RF 59 % and 91 %. Patients harboring anti-CarP antibodies not classified as RA were mainly diagnosed with undifferentiated arthritis and less frequently reactive arthritis and psoriatic arthritis.

Conclusion

Anti-CarP antibodies are predominantly present in RA but can also be detected in other forms of arthritis.

Source:

Arthritis Research and therapy

Article:

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis

Authors:

Jing Shi et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: